COVID-19 Research

The COVID-19 pandemic has placed sustained pressure on Canada’s healthcare system and resources, including prescription drugs. In line with the ODPRN’s goal of being a leader in generating high-quality, relevant, and timely research of interest to clinicians, policy-makers, academics, and the general public, the ODPRN is conducting several projects examining the impacts of the pandemic on medication use and drug safety.

wdt_ID Title Publication Type Date Released Research Topic Additional Resources
wdt_ID Title Publication Type Date Released Research Topic Additional Resources
1 Long-term analgesic use after low-risk surgery Journal Article 12 Mar 2012 Descriptive and Utilization Trends Letter to Editor
3 Trends in opioid use and dosing among socio-economically disadvantaged patients Journal Article 25 Jan 2011 Descriptive and Utilization Trends
4 Clustering of opioid prescribing and opioid-related mortality among family physicians in Ontario Journal Article 01 Mar 2011 Descriptive and Utilization Trends
5 Use of other opioids during methadone therapy: A population-based study Journal Article 18 Jan 2012 Descriptive and Utilization Trends
6 Trends in high-dose opioid prescribing in Canada Journal Article 01 Sep 2014 Descriptive and Utilization Trends Research Minute
7 Opioid use and related adverse events in Ontario Public Report 10 Nov 2016 Descriptive and Utilization Trends County Report Cards
8 Opioid prescribing and opioid-related hospital visits in Ontario Public Report 01 Jul 2015 Descriptive and Utilization Trends
9 The burden of premature opioid-related mortality Public Report 01 May 2014 Descriptive and Utilization Trends Research Minute
10 Prescribing of opioids and opioid-related mortality in Ontario: 2004-2006 Public Report 01 Jul 2012 Descriptive and Utilization Trends
11 Evaluating the effectiveness of first-time methadone maintenance therapy across northern rural and urban regions of Ontario Journal Article 03 Nov 2015 Drug Adherence Research Minute
12 Reformulation of controlled-release oxycodone and pharmacy dispensing patterns near the US–Canada border Journal Article 13 Nov 2012 Pharmacy Practices and Services Research Minute
13 Effect of a course-based intervention and effect of medical regulation on physicians’ opioid prescribing Journal Article 01 May 2013 Policy Analysis Research Minute
15 High strength opioid formulations in Ontario: By the numbers Public Report 02 Aug 2016 Descriptive and Utilization Trends Infographic
18 Opioid dose and drug-related mortality in patients with nonmalignant pain Journal Article 11 Apr 2011 Real-world Safety and Effectiveness
19 Postpartum maternal codeine therapy and the risk of adverse neonatal outcomes: A retrospective cohort study Journal Article 27 Apr 2012 Real-world Safety and Effectiveness
22 Neonatal opioid withdrawal and antenatal opioid prescribing Journal Article 11 Feb 2015 Real-world Safety and Effectiveness Research Minute
23 Sex differences in dose escalation and overdose death during chronic opioid therapy: A population-based cohort study Journal Article 20 Aug 2015 Real-world Safety and Effectiveness Research Minute
24 Safety and use of opioids: A summary of ODPRN research on prescription opioid use in Ontario Public Report 01 Aug 2016 Real-world Safety and Effectiveness
25 Sensitivity and specificity of administrative mortality data for identifying prescription opioid-related deaths Journal Article 30 Nov 2015 Methodology
38 Ontario Prescription Opioid Tool (June 2021 update) Public Report 24 Jun 2021 Descriptive and Utilization Trends Technical Appendix
61 A qualitative study of a publicly funded pharmacy-dispensed naloxone program Journal Article 07 Feb 2021 Qualitative Infographic
62 Prescription opioid characteristics at initiation for non-cancer pain and risk of treated opioid use disorder: A population-based study Journal Article 19 Feb 2021 Real-world Safety and Effectiveness
63 Dental opioid prescription characteristics and the risk of new, persistent use Journal Article 17 Mar 2021 Real-world Safety and Effectiveness Infographic
64 Changing circumstances surrounding opioid-related deaths in Ontario during the COVID-19 pandemic Public Report 19 May 2021 Descriptive and Utilization Trends Infographic
65 Measuring the burden of opioid-related mortality in Ontario, Canada, during the COVID-19 pandemic Journal Article 26 May 2021 Descriptive and Utilization Trends
Please note that this report is NOT COMPLETE and is still in progress. Click below if you would like to continue.